Development	O
and	O
validation	O
of	O
an	O
approach	O
to	O
produce	O
large	O
-	O
scale	O
quantities	O
of	O
CpG	O
-	O
methylated	O
plasmid	B-Cellular_component
DNA	O
.	O

The	O
prokaryotic	O
CpG	O
-	O
specific	O
DNA	O
methylase	O
from	O
Spiroplasma	O
,	O
SssI	O
methylase	O
,	O
has	O
been	O
extensively	O
used	O
to	O
methylate	O
plasmid	B-Cellular_component
DNA	O
in	O
vitro	O
to	O
investigate	O
the	O
effects	O
of	O
methylation	O
in	O
vertebrate	O
systems	O
.	O

Currently	O
available	O
methods	O
to	O
produce	O
CpG	O
-	O
methylated	O
plasmid	B-Cellular_component
DNA	O
have	O
certain	O
limitations	O
and	O
cannot	O
generate	O
large	O
quantities	O
of	O
methylated	O
DNA	O
without	O
cost	O
or	O
problems	O
of	O
purity	O
.	O

Here	O
we	O
describe	O
an	O
approach	O
in	O
which	O
the	O
SssI	O
methylase	O
gene	O
has	O
been	O
introduced	O
into	O
the	O
Escherichia	O
coli	O
bacterial	O
genome	O
under	O
the	O
control	O
of	O
an	O
inducible	O
promoter	O
.	O

Plasmid	B-Cellular_component
DNA	O
propagated	O
in	O
this	O
bacterium	O
under	O
conditions	O
which	O
induce	O
the	O
methylase	O
gene	O
result	O
in	O
significant	O
(	O
>	O
90	O
%	O
)	O
CpG	O
methylation	O
.	O

Methylated	O
DNA	O
produced	O
by	O
this	O
approach	O
behaves	O
similarly	O
to	O
methylated	O
DNA	O
produced	O
in	O
vitro	O
using	O
the	O
purified	O
methylase	O
.	O

The	O
approach	O
is	O
scalable	O
allowing	O
for	O
the	O
production	O
of	O
milligram	O
quantities	O
of	O
methylated	O
plasmid	B-Cellular_component
DNA	O
.	O

